Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
46 Prestige Biopharma IDC Selected for National Drug Development Project for TNBC Program
김** | 2025.11.25 | Votes 0 | Views 668
김** 2025.11.25 0 668
45 Prestige Biopharma Secures Herceptin Biosimilar Supply Deal in South America
김** | 2025.11.24 | Votes 0 | Views 731
김** 2025.11.24 0 731
44 Busan Mayor Visits Prestige Biopharma IDC to Support Regional Bioindustry Growth
김** | 2025.11.05 | Votes 0 | Views 441
김** 2025.11.05 0 441
43 Prestige Biopharma Presents PAUF-Based Pancreatic Cancer Program at ESMO 2025
we******** | 2025.10.21 | Votes 0 | Views 505
we******** 2025.10.21 0 505
42 Prestige Biopharma IDC Files Patent for Sustained-Release Subcutaneous Delivery Platform for High-Concentration Protein Therape
김** | 2025.10.14 | Votes 0 | Views 492
김** 2025.10.14 0 492
41 Prestige Biopharma IDC Publishes IHC-Based PAUF Diagnostic Platform Study in International Journal
we******** | 2025.09.17 | Votes 0 | Views 345
we******** 2025.09.17 0 345
40 Prestige Biopharma IDC Signs Joint Development Agreement with Geovista for Companion Animal Therapeutics
김** | 2025.09.16 | Votes 0 | Views 394
김** 2025.09.16 0 394
39 Prestige Biopharma IDC Selected as a Core Research center in Korea’s ARPA-H Project
김** | 2025.08.20 | Votes 0 | Views 388
김** 2025.08.20 0 388
38 PPrestige Biopharma Secures European Patent for Pancreatic Cancer Antibody PBP1510
김** | 2025.08.01 | Votes 0 | Views 417
김** 2025.08.01 0 417
37 Prestige Biopharma IDC Files Patent for Anti-CTHRC1 Antibody Combination Therapy for Solid Tumors
we******** | 2025.07.28 | Votes 0 | Views 285
we******** 2025.07.28 0 285